ホーム>>Peptides>>Tyr-Gly-Gly-Phe-Met-OH (Met-Enkephalin)

Tyr-Gly-Gly-Phe-Met-OH (Met-Enkephalin)

カタログ番号GC30816

Tyr-Gly-Gly-Phe-Met-OH (Met-エンケファリン) は、オピオイド受容体への結合を介してヒトの免疫機能を調節し、腫瘍の成長を阻害します。

Products are for research use only. Not for human use. We do not sell to patients.

Tyr-Gly-Gly-Phe-Met-OH (Met-Enkephalin) 化学構造

Cas No.: 58569-55-4

サイズ 価格 在庫数 個数
10mM (in 1mL Water)
$50.00
在庫あり
25mg
$88.00
在庫あり
50mg
$147.00
在庫あり
100mg
$239.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Tyr-Gly-Gly-Phe-Met-OH regulates human immune function and inhibits tumor growth via binding to the opioid receptor.

Methionine enkephalin (MENK), an endogenous neuropeptide has a crucial role in both neuroendocrine and immune systems. MENK is believed to have an immunoregulatory activity to have cancer biotherapy activity by binding to the opioid receptors on immune and cancer cells. MENK may also change the tumor microenvironment by binding to opioid receptor on or in cancer cells. All of these mechanisms of action have biologic significance and potential for use in cancer immunotherapy. Furthermore, they reveal a relationship between the endocrine and immune systems[1].

[1]. Zhao D, et al. Methionine enkephalin, its role in immunoregulation and cancer therapy. Int Immunopharmacol. 2016 Feb 23. pii: S1567-5769(16)30050-9.

レビュー

Review for Tyr-Gly-Gly-Phe-Met-OH (Met-Enkephalin)

Average Rating: 5 ★★★★★ (Based on Reviews and 39 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Tyr-Gly-Gly-Phe-Met-OH (Met-Enkephalin)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.